Mark  Kindy  to  Oligopeptides
                            
                            
                                This is a "connection" page, showing publications  Mark  Kindy  has written about  Oligopeptides.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.959
         
        
        
     
 
    
        
        - 
            GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
            
            
                Score: 0.588
             
- 
            Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
            
            
                Score: 0.265
             
- 
            Delta 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic neuroprotection. Acad Emerg Med. 2008 Mar; 15(3):250-7.
            
            
                Score: 0.069
             
- 
            Enzyme-linked immunosorbent assay for an octapeptide based on a genetically engineered fusion protein. Anal Chem. 1993 May 01; 65(9):1147-51.
            
            
                Score: 0.025
             
- 
            RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
            
            
                Score: 0.012